Steve Colletti
About Steve Colletti
Steve Colletti, with nearly 30 years of experience in drug discovery and development, currently serves as the Chief Scientific Officer, having held significant roles at Zymergen, Lodo Therapeutics, and Merck.
Steve Colletti's Role as Chief Scientific Officer
Steve Colletti is the Chief Scientific Officer, leveraging nearly 30 years of experience in drug discovery and development. His expertise spans a broad range of therapeutic areas and modalities, encompassing everything from small molecules to complex fusion protein bioconjugates.
Steve Colletti's Tenure at Merck
With nearly 25 years at Merck, Steve Colletti held multiple roles focusing on small molecule, natural products, oligonucleotide, peptide, and fusion protein bioconjugate drug discovery. He was instrumental in leading programs targeting cardiovascular and respiratory diseases, diabetes and obesity, immunological disorders, infectious diseases, neuroscience, and oncology.
Steve Colletti's Leadership in Innovating Drug Discovery
Steve Colletti served as the SVP of Drug Discovery R&D at Zymergen and CSO at Lodo Therapeutics. He has built and led the RNA Therapeutics Medicinal Chemistry department, contributed to the discovery of over a dozen preclinical candidates, and played a key role in their advancement to clinical development.
Steve Colletti's Contributions to Scientific Literature
Steve Colletti is an inventor and author with over 130 patents and publications. His work has had a significant impact on the field of medicinal chemistry and drug discovery, providing valuable insights and innovations.
Steve Colletti's Academic Background in Chemistry
Steve Colletti received his Ph.D. in chemistry from Boston University. He furthered his expertise as a National Institutes of Health postdoctoral fellow in chemistry at the Scripps Research Institute, cementing a strong foundation for his illustrious career in drug discovery and development.